期刊文献+

不同类型老年乙型肝炎患者的HBV-DNA、HBsAg定量检测结果 被引量:2

The Results of Quantitative Detection of HBV-DNA、HBsAg in Different Types of Elderly Patients with Hepatitis B
下载PDF
导出
摘要 目的探讨HBV-DNA、HBsAg定量检测在不同类型老年乙型肝炎患者诊治中的应用价值。方法选取2013年7月至2018年7月医院收治的老年慢性乙型肝炎患者80例作为试验组;选取同期的老年乙型肝炎肝硬化患者80例作为对照组。对两组进行HBV-DNA和HBsAg定量检测并对比,分析不同类型老年乙型肝炎患者HBV-DNA与HBsAg的特点及其相关性。结果两组的HBsAg与HBV-DNA均成正相关。试验组的HBsAg与HBV-DNA均高于对照组,差异有统计学意义(P<0.05)。结论 HBV-DNA与HBsAg定量检测是体现老年慢性乙型肝炎患者与老年乙型肝炎肝硬化患者病情的基准指标。 Objective To analyse the application value of quantitative detection of HBV-DNA、HBsAg in the diagnosis and treatment of different types of elderly patients with hepatitis B.Methods Confirmed elderly patients with chronic hepatitis B accepted in our hospital from July 2013 to July 2018(total 80 cases),and let elderly patients with hepatitis B cirrhosis(total 80 cases)as the control group.Through quantitative detection and comparison of HBV-DNA and HBsAg,to discuss the characteristics and correlation of HBV-DNA and HBsAg in different types of elderly patient with hepatitis B.Results The level of HBsAg was positively correlated with the level of HBV-DNA in the two groups.Furthermore,the HBsAg level and the quantitative level of HBV-DNA in the experimental group were higher than that in the control group.The testing data was with the differences statistically significant(P<0.05).Conclusion The quantitative detection of HBV-DNA、HBsAg is a benchmark indicator reflecting the condition of elderly patients with chronic hepatitis B and elderly patients with hepatitis B cirrhosis.
作者 张惠菊 梁小亮 Zhang Huiju;Liang Xiaoliang(Department of Clinical Laboratory,the Second Affiliated Hospital of Xiamen Medical College,Xiamen Fujian 361021,China)
出处 《医疗装备》 2019年第7期54-55,共2页 Medical Equipment
关键词 老年患者 乙型肝炎 HBV-DNA HBSAG Elderly patients Chronic hepatitis B HBV-DNA HBsAg
  • 相关文献

参考文献4

二级参考文献42

  • 1张艳玲,李永浩.肝癌中医证型与客观指标关系的研究进展[J].中医药导报,2007,13(5):95-96. 被引量:5
  • 2陈灏珠 主编.实用内科学[M].北京:人民卫生出版社,2003.1866.
  • 3Moucari R, Mackiewicz V,Lada O, et al. Early serumHBsAg drop: a strong predictor of sustained virologicalresponse to pegylated interferon alfa-2a in HBeAg-nega-tive patients[J]. Hepatol, 2009, 49(4) :1151-1157.
  • 4Cai W, Xie Q, An B, et al. On-treatment serum HBsAglevel is predictive of sustained off-treatment virologic re-sponse to telbivudine in HBeAg positive chronic hepatitisB patients [J]. J Clin Virol, 2010,48(1) :22-26.
  • 5Tseng T C, Liu C J, Yang H C, et al. Determinants ofspontaneous surface antigen loss in HBeAg-negative pa-tients with a low viral load [ J ]. Hepatol,2012, 55 (1):68-76.
  • 6Chen Y C,Jeng W J, Chu C M, et al. Decreasing levelsof HBsAg predict HBsAg seroclearance in patients withinactive chronic hepatitis B virus infection [ J ]. Clin Gas-troenterol Hepatol, 2012,10(3) :297-302.
  • 7Nguyen T, Thompson A J, Bowden S,et al. Hepatitis Bsurface antigen levels during the natural history of chronichepatitis B : a perspective on Asia[ J ]. Hepatol,2010,52(4):508-513.
  • 8Kim Y J, Cho H C,Choi M S, et al. The change of thequantitative HBsAg level during the natural course ofchronic hepatitis B [ J ]. Liver Int, 2011,31(6): 817-823.
  • 9Jang J W,Yoo S H, Kwon J H, et al. Serum hepatitis Bsurface antigen levels in the natural history of chronic hep-atitis B infection[ J]. Aliment Pharmacol Ther, 2011, 34(11-12) :1337-1346.
  • 10Wong D K,Yuen M F,Poon R T, et al. Quantificationof hepatitis B virus covalently closed circular DNA in pa-tients with hepatocellular carcinoma [ J ]. J Hepatol,2006,45(4) :553-559.

共引文献28

同被引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部